Simpson Thacher is representing Facet Biotech Corporation in connection with the unsolicited proposal made by Biogen Idec Inc. to acquire all outstanding shares of Facet Biotech. Facet Biotech is a biotechnology company which launched in December 2008 as a spin-off from PDL BioPharma, Inc.
The Simpson Thacher team includes: Rob Spatt, Rich Capelouto, Kirsten Jensen, Robert Bartlett, Jared Grauer and Grace Park.
